---

Mispa count X; The first indigenous indian hematology 3-part analyzer

---

Original Article

Author Details : Deepa K Vijayan*, Jiby Krishna K G, Dinimol Danniel, Ashily Shaji, Jojo Mathew, Arun John, Ajaikumar Sukumaran, Peeter K Varkey, Thushara Thomas, Riji Thomas

Volume : 8, Issue : 4, Year : 2021

Article Page : 265-273

https://doi.org/10.18231/j.ijcbr.2021.057

Suggest article by email

Get Permission

---

Abstract

Background: Impedance technology was a revolution in the history of Hematology. Mispa Count X is the first indigenous 3-part hematology analyzer in India, which works on the principle of impedance technology.
Aim: Performance evaluation of Mispa Count X.
Design & Methods: The analyzer produces the measurement results of 18 parameters with throughput of 60 samples per hour. Mispa Count X was compared with benchmark analyzers Coulter DxH 800 and Sysmex XN 1000 to validate its performance.
Result & Discussion: Mispa Count X exhibited a wide linearity range for WBC, RBC, platelet and hemoglobin. The carry over for WBC, RBC, PLT and Hb was estimated and found to be well within the acceptable limits. The r values (> 0.90) and bias estimation of Mispa Count X on comparing with Coulter DxH 800 and Sysmex XN 1000 were acceptable, except for mid cell counts and for MPV. Mispa Count X exhibited good precision with an acceptable CV% (< 10> Conclusion: So we conclude our study by proving that the Mispa Count X would be an affordable-reliable alternative for Indian healthcare sector instead of expensive imported hematology analyzers.

Keywords: Performance evaluation of Mispa Count X Blood cell counters, Cell counter verification, Hematology analyzer, Impedance technology, Mispa count X evaluation, Performance evaluation.

How to cite : Vijayan D K, Jiby Krishna K G, Danniel D, Shaji A, Mathew J, John A, Sukumaran A, Varkey P K, Thomas T, Thomas R, Mispa count X; The first indigenous indian hematology 3-part analyzer. Int J Clin Biochem Res 2021;8(4):265-273

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.